HEADER STRUCTURAL PROTEIN 29-JUN-18 6A6P
TITLE CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA
TITLE 2 (PPARD)LBD IN COMPLEX WITH DN003316
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: PPAR-DELTA,NUCI,NUCLEAR HORMONE RECEPTOR 1,NUC1,NUCLEAR
COMPND 5 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2,PEROXISOME PROLIFERATOR-
COMPND 6 ACTIVATED RECEPTOR BETA,PPAR-BETA;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PPARD, NR1C2, PPARB;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS PPARDELTA, COMPLEX, NUCLEAR RECEPTOR, PEROXISOME PROLIFERATOR-
KEYWDS 2 ACTIVATED RECEPTOR FAMILY, LIGAND BINDING DOMAIN (LBD), STRUCTURAL
KEYWDS 3 PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR J.W.CHIN,S.J.CHO,J.Y.SONG,J.H.HA
REVDAT 3 22-NOV-23 6A6P 1 HETSYN
REVDAT 2 29-JUL-20 6A6P 1 COMPND REMARK HETNAM SITE
REVDAT 2 2 1 ATOM
REVDAT 1 10-JUL-19 6A6P 0
JRNL AUTH J.W.CHIN,S.J.CHO,J.Y.SONG,J.H.HA
JRNL TITL CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED
JRNL TITL 2 RECEPTOR DELTA (PPARD)LBD IN COMPLEX WITH DN003316
JRNL REF TO BE PUBLISHED
JRNL REFN
REMARK 2
REMARK 2 RESOLUTION. 2.10 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (1.13_2998)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.20
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4
REMARK 3 NUMBER OF REFLECTIONS : 41144
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.195
REMARK 3 R VALUE (WORKING SET) : 0.194
REMARK 3 FREE R VALUE : 0.228
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920
REMARK 3 FREE R VALUE TEST SET COUNT : 2025
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 38.2071 - 5.0577 1.00 2913 134 0.1766 0.1824
REMARK 3 2 5.0577 - 4.0158 1.00 2847 142 0.1540 0.1890
REMARK 3 3 4.0158 - 3.5086 1.00 2879 148 0.1742 0.2084
REMARK 3 4 3.5086 - 3.1880 1.00 2862 119 0.1986 0.2499
REMARK 3 5 3.1880 - 2.9596 1.00 2826 147 0.2134 0.2492
REMARK 3 6 2.9596 - 2.7852 1.00 2815 179 0.2107 0.2876
REMARK 3 7 2.7852 - 2.6457 1.00 2784 147 0.2077 0.2589
REMARK 3 8 2.6457 - 2.5306 1.00 2852 157 0.2143 0.2264
REMARK 3 9 2.5306 - 2.4332 0.99 2802 163 0.2107 0.2432
REMARK 3 10 2.4332 - 2.3492 0.99 2783 152 0.2127 0.2409
REMARK 3 11 2.3492 - 2.2758 0.99 2806 149 0.2205 0.2679
REMARK 3 12 2.2758 - 2.2107 0.98 2753 137 0.2370 0.2755
REMARK 3 13 2.2107 - 2.1525 0.98 2799 134 0.2697 0.2977
REMARK 3 14 2.1525 - 2.1000 0.85 2398 117 0.2984 0.3318
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.130
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.008 4576
REMARK 3 ANGLE : 0.994 6155
REMARK 3 CHIRALITY : 0.054 689
REMARK 3 PLANARITY : 0.007 759
REMARK 3 DIHEDRAL : 17.165 2747
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: ALL
REMARK 3 ORIGIN FOR THE GROUP (A): -0.8173 25.7103 24.3599
REMARK 3 T TENSOR
REMARK 3 T11: 0.2338 T22: 0.2862
REMARK 3 T33: 0.2099 T12: -0.0018
REMARK 3 T13: -0.0032 T23: -0.0092
REMARK 3 L TENSOR
REMARK 3 L11: 0.3994 L22: 0.9581
REMARK 3 L33: 0.3141 L12: 0.0900
REMARK 3 L13: -0.0414 L23: -0.2966
REMARK 3 S TENSOR
REMARK 3 S11: 0.0022 S12: -0.0216 S13: 0.0000
REMARK 3 S21: -0.0404 S22: 0.0177 S23: -0.0206
REMARK 3 S31: -0.0390 S32: 0.0638 S33: -0.0168
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6A6P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-JUN-18.
REMARK 100 THE DEPOSITION ID IS D_1300008241.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 18-JUN-18
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : PAL/PLS
REMARK 200 BEAMLINE : 5C (4A)
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97960
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41153
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3
REMARK 200 DATA REDUNDANCY : 5.300
REMARK 200 R MERGE (I) : 0.10240
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.0100
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: 5U3R
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 58.62
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2~0.3M SODIUM FLOURIDE, 0.1M MES(PH
REMARK 280 6.5), LIQUID DIFFUSION, TEMPERATURE 291.15K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.87450
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1780 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13220 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1820 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13400 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LYS A 229
REMARK 465 GLN A 230
REMARK 465 LEU A 231
REMARK 465 VAL A 232
REMARK 465 GLN B 230
REMARK 465 LEU B 231
REMARK 465 VAL B 232
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 SG CYS B 251 H362 PE3 B 503 1.54
REMARK 500 SG CYS B 251 C36 PE3 B 503 1.77
REMARK 500 O LYS B 438 O3 B7G B 502 1.81
REMARK 500 O HOH B 658 O HOH B 692 1.82
REMARK 500 SG CYS B 251 O37 PE3 B 503 1.98
REMARK 500 NH2 ARG A 318 O HOH A 601 2.05
REMARK 500 NH1 ARG B 379 O HOH B 601 2.07
REMARK 500 OG1 THR A 280 O HOH A 602 2.10
REMARK 500 N GLY B 234 O HOH B 602 2.15
REMARK 500 O GLU B 223 O HOH B 603 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 379 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLU A 240 172.28 174.31
REMARK 500 HIS A 389 77.27 -116.35
REMARK 500 GLU A 424 78.79 -107.89
REMARK 500 ASP A 439 75.59 66.29
REMARK 500 SER B 206 -7.25 -54.27
REMARK 500 LYS B 224 -169.13 -71.43
REMARK 500 GLU B 240 170.39 175.06
REMARK 500 HIS B 389 79.18 -115.22
REMARK 500 GLU B 424 76.21 -104.02
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A 724 DISTANCE = 6.09 ANGSTROMS
REMARK 525 HOH A 725 DISTANCE = 7.81 ANGSTROMS
DBREF 6A6P A 171 440 UNP Q03181 PPARD_HUMAN 171 440
DBREF 6A6P B 171 440 UNP Q03181 PPARD_HUMAN 171 440
SEQRES 1 A 270 GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE TYR
SEQRES 2 A 270 ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS LYS
SEQRES 3 A 270 ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR ALA
SEQRES 4 A 270 PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN ALA
SEQRES 5 A 270 GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU
SEQRES 6 A 270 PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR ARG
SEQRES 7 A 270 CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU THR
SEQRES 8 A 270 GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU PHE
SEQRES 9 A 270 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS
SEQRES 10 A 270 GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN LYS
SEQRES 11 A 270 ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL THR
SEQRES 12 A 270 ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER ASP
SEQRES 13 A 270 ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN
SEQRES 14 A 270 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE ILE
SEQRES 15 A 270 ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU MET
SEQRES 16 A 270 ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE LEU
SEQRES 17 A 270 ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP
SEQRES 18 A 270 ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET ALA
SEQRES 19 A 270 ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET MET
SEQRES 20 A 270 GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU HIS
SEQRES 21 A 270 PRO LEU LEU GLN GLU ILE TYR LYS ASP MET
SEQRES 1 B 270 GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE TYR
SEQRES 2 B 270 ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS LYS
SEQRES 3 B 270 ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR ALA
SEQRES 4 B 270 PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN ALA
SEQRES 5 B 270 GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU
SEQRES 6 B 270 PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR ARG
SEQRES 7 B 270 CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU THR
SEQRES 8 B 270 GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU PHE
SEQRES 9 B 270 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS
SEQRES 10 B 270 GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN LYS
SEQRES 11 B 270 ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL THR
SEQRES 12 B 270 ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER ASP
SEQRES 13 B 270 ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN
SEQRES 14 B 270 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE ILE
SEQRES 15 B 270 ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU MET
SEQRES 16 B 270 ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE LEU
SEQRES 17 B 270 ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP
SEQRES 18 B 270 ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET ALA
SEQRES 19 B 270 ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET MET
SEQRES 20 B 270 GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU HIS
SEQRES 21 B 270 PRO LEU LEU GLN GLU ILE TYR LYS ASP MET
HET 9RF A 501 43
HET B7G A 502 45
HET PE3 A 503 101
HET 9RF B 501 43
HET B7G B 502 45
HET PE3 B 503 101
HETNAM 9RF {2-METHYL-4-[({5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4-
HETNAM 2 9RF THIADIAZOL-2-YL}METHYL)SULFANYL]PHENOXY}ACETIC ACID
HETNAM B7G HEPTYL BETA-D-GLUCOPYRANOSIDE
HETNAM PE3 3,6,9,12,15,18,21,24,27,30,33,36,39-
HETNAM 2 PE3 TRIDECAOXAHENTETRACONTANE-1,41-DIOL
HETSYN B7G HEPTYL-BETA-D-GLUCOPYRANOSIDE; HEPTYL BETA-D-GLUCOSIDE;
HETSYN 2 B7G HEPTYL D-GLUCOSIDE; HEPTYL GLUCOSIDE
HETSYN PE3 POLYETHYLENE GLYCOL
FORMUL 3 9RF 2(C19 H15 F3 N2 O3 S2)
FORMUL 4 B7G 2(C13 H26 O6)
FORMUL 5 PE3 2(C28 H58 O15)
FORMUL 9 HOH *223(H2 O)
HELIX 1 AA1 ALA A 173 PHE A 190 1 18
HELIX 2 AA2 THR A 193 THR A 202 1 10
HELIX 3 AA3 ASP A 215 LYS A 224 1 10
HELIX 4 AA4 GLU A 240 SER A 266 1 27
HELIX 5 AA5 ILE A 267 SER A 272 1 6
HELIX 6 AA6 PHE A 274 ALA A 295 1 22
HELIX 7 AA7 ARG A 314 SER A 319 1 6
HELIX 8 AA8 PRO A 323 ILE A 328 1 6
HELIX 9 AA9 ILE A 328 LEU A 341 1 14
HELIX 10 AB1 ASP A 344 LEU A 357 1 14
HELIX 11 AB2 ASN A 366 HIS A 389 1 24
HELIX 12 AB3 TYR A 394 GLU A 424 1 31
HELIX 13 AB4 HIS A 430 LYS A 438 1 9
HELIX 14 AB5 ASP B 174 PHE B 190 1 17
HELIX 15 AB6 THR B 193 THR B 202 1 10
HELIX 16 AB7 ASP B 215 LYS B 224 1 10
HELIX 17 AB8 GLU B 240 SER B 266 1 27
HELIX 18 AB9 ILE B 267 SER B 272 1 6
HELIX 19 AC1 PHE B 274 ALA B 295 1 22
HELIX 20 AC2 ARG B 314 SER B 319 1 6
HELIX 21 AC3 PRO B 323 ILE B 327 5 5
HELIX 22 AC4 ILE B 328 LEU B 341 1 14
HELIX 23 AC5 ASP B 344 LEU B 357 1 14
HELIX 24 AC6 ASN B 366 HIS B 389 1 24
HELIX 25 AC7 TYR B 394 GLU B 424 1 31
HELIX 26 AC8 HIS B 430 LYS B 438 1 9
SHEET 1 AA1 4 PHE A 211 ILE A 213 0
SHEET 2 AA1 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213
SHEET 3 AA1 4 GLY A 302 VAL A 305 -1 N LEU A 303 O VAL A 312
SHEET 4 AA1 4 VAL A 298 ASN A 299 -1 N ASN A 299 O GLY A 302
SHEET 1 AA2 4 PHE B 211 ILE B 213 0
SHEET 2 AA2 4 GLY B 310 THR B 313 1 O PHE B 311 N PHE B 211
SHEET 3 AA2 4 GLY B 302 VAL B 305 -1 N LEU B 303 O VAL B 312
SHEET 4 AA2 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302
CISPEP 1 LYS A 322 PRO A 323 0 4.71
CISPEP 2 LYS B 322 PRO B 323 0 6.20
CRYST1 39.605 95.749 96.936 90.00 97.91 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.025249 0.000000 0.003506 0.00000
SCALE2 0.000000 0.010444 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010415 0.00000